KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Prepaid Assets (2016 - 2025)

Pfizer (PFE) has disclosed Prepaid Assets for 14 consecutive years, with $2.8 billion as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 33.98% to $2.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.8 billion, a 33.98% decrease, with the full-year FY2025 number at $2.8 billion, down 33.98% from a year prior.
  • Prepaid Assets was $2.8 billion for Q4 2025 at Pfizer, up from $2.4 billion in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $6.1 billion in Q4 2022 to a low of $2.4 billion in Q3 2025.
  • A 5-year average of $4.2 billion and a median of $4.2 billion in 2022 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: soared 62.24% in 2022, then crashed 38.83% in 2025.
  • Pfizer's Prepaid Assets stood at $3.8 billion in 2021, then surged by 31.34% to $5.0 billion in 2022, then dropped by 2.11% to $4.9 billion in 2023, then dropped by 13.4% to $4.3 billion in 2024, then plummeted by 33.98% to $2.8 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Prepaid Assets are $2.8 billion (Q4 2025), $2.4 billion (Q3 2025), and $2.7 billion (Q2 2025).